Joe Biden has been re-infected with COVID after taking an anti-viral drug that leaves patients running a 40 per cent risk of flare-up of the virus shortly afterwards.
- Taking Paxlovid leaves COVID sufferers in danger of testing positive for the virus again very quickly after clearing their initial infection.
- When Paxlovid came to market in December 2021, studies from Pfizer indicated that only 1-2 percent of patients who took the drug tested positive for COVID again shortly after finishing their dosage.
But other experts say the rapid reinfection rate is closer to 40 per cent, and that Paxlovid can cause this issue by suppressing patients’ immune systems too early, meaning their own bodies are unable to get a handle on COVID.
Dr. Jonathan Reiner, a prominent cardiologist and professor of medicine and surgery at George Washington University Hospital tweeted: ‘I think this was predictable.’
He continued: ‘The prior data suggesting ‘rebound’ Paxlovid positivity in the low single digits is outdates and with BA.5 is likely 20-40% or even higher.’
In a memo released by the White House, Dr. Kevin O’Connor said that the president will continue to isolate, just like he did when he first tested positive on July 21.
Dr. O’Connor also said that the president would not be prescribed Paxlovid again. The president’s doctor earlier noted that it was likely that the president was infected with the BA.5 variant.
- In June, a Mayo Clinic study showed that five percent of adults who had taken the drug tested positive again for COVID within 30 days, according to the New York Times.
- The majority of those who experienced rebound symptoms occur within two to eight days.
Source: DAILY MAIL